These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21010147)

  • 1. Immune serum in the prophylaxis and treatment of virus diseases.
    LEVINSON SO; SHAUGHNESSY HJ
    Med Clin North Am; 1946 Jan; 30():61-73. PubMed ID: 21010147
    [No Abstract]   [Full Text] [Related]  

  • 2. The virus-neutralising power of serum from recently vaccinated persons.
    LOUTIT JF; McCLEAN D
    J Pathol Bacteriol; 1945 Oct; 57():485-8. PubMed ID: 21012480
    [No Abstract]   [Full Text] [Related]  

  • 3. The serology of Newcastle virus infection. I. The reaction between various sera and the virus.
    BANG FB; FOARD M
    J Immunol; 1956 May; 76(5):342-7. PubMed ID: 13319713
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of time of contact at 37 C and hydrogen ion concentration on the degree of neutralization of equine encephalomyelitis virus (Eastern type) by immune serum.
    LABZOFFSKY NA
    J Infect Dis; 1946; 79():63-8. PubMed ID: 20996929
    [No Abstract]   [Full Text] [Related]  

  • 5. [The importance of antiviral diagnostic sera].
    Mlinarić-Galinović G
    Lijec Vjesn; 1992; 114(1-4):67-9. PubMed ID: 1343032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROBLEMS IN THE PREPARATION OF DIAGNOSTIC AND REFERENCE ANTIGENS AND ANTISERA.
    SCHAEFFER M
    Am Rev Respir Dis; 1963 Sep; 88():SUPPL 339-41. PubMed ID: 14064947
    [No Abstract]   [Full Text] [Related]  

  • 7. The production of antisera that neutralize inclusion blennorrhoea virus.
    BLYTH WA; REEVE P; GRAHAM DM; TAVERNE J
    Br J Exp Pathol; 1962 Jun; 43(3):340-3. PubMed ID: 13870266
    [No Abstract]   [Full Text] [Related]  

  • 8. PATTERNS OF "LIPOVIRUS" ANTIBODY IN HUMAN POPULATIONS.
    CHANG RS; OWENS S
    J Immunol; 1964 Feb; 92():313-9. PubMed ID: 14160453
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of the complement-fixation reaction in virus systems; activities of vaccinia virus antigens and antisera.
    RICE CE
    J Immunol; 1946 Jul; 53(3):225-36. PubMed ID: 20992659
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppression: a means to assess the role of the immune response in acute virus infections.
    Nathanson N; Cole GA
    Fed Proc; 1971; 30(6):1822-30. PubMed ID: 5001450
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of defense against virus infections].
    Lahelle O
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):76-8. PubMed ID: 5539607
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural and acquired immunity to influenza; the reactivation of the influenza virus from an immune serum-virus mixture.
    SMORODINTSEV AA; SHISHKINA OI
    Am Rev Sov Med; 1946 Jun; 3():400-13. PubMed ID: 20985829
    [No Abstract]   [Full Text] [Related]  

  • 13. PROTECTIVE EFFECT OF ANTIBODY OR ELEVATED TEMPERATURE ON INTRACEREBRAL INFECTION OF MICE WITH ENCEPHALOMYCARDITIS VIRUS.
    BARON S; BUCKLER CE
    J Immunol; 1964 Jul; 93():45-50. PubMed ID: 14214388
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of viruses on immune response.
    Allison AC; Virelizier JL
    Adv Nephrol Necker Hosp; 1975; 5():115-33. PubMed ID: 171931
    [No Abstract]   [Full Text] [Related]  

  • 15. IMMUNITY to virus diseases.
    Nature; 1948 Jul; 162(4107):92. PubMed ID: 18869695
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of induction of immunity to virus infections: interruption of intercellular virus multiplication].
    Uetake H; Hamada C; Nakajima S
    Tanpakushitsu Kakusan Koso; 1972 Nov; 17(11):835-47. PubMed ID: 4346822
    [No Abstract]   [Full Text] [Related]  

  • 17. FIRST ISOLATION OF WEST NILE VIRUS IN CENTRAL AFRICA.
    LUCASSE C
    Bull Soc Pathol Exot Filiales; 1963; 56():156-61. PubMed ID: 14073525
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inherent specific immunity as basis for preventive and therapeutic use of homologous antibodies].
    AUERSWALD W
    Wien Z Inn Med; 1954 Apr; 35(4):157-63. PubMed ID: 13196374
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cross immunity tests between RH strains of Toxoplasma gondii and its associated filterable virus].
    Fabio U; Provvisionato CA; Olivo R
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(5):173-8. PubMed ID: 5004723
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity to virus disease.
    JANEWAY CA
    Bull New Engl Med Cent; 1947 Apr; 9(2):68-73. PubMed ID: 20291310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.